The global kidney stone market size was valued at USD 2.84 billion in 2025 and is projected to grow from USD 2.96 billion in 2026 to USD 4.14 billion by 2034 at a CAGR of 4.3% during the forecast period 2026-2034. North America dominated the kidney stone market with a market share of 38.4% in 2025.
Kidney stone, also known as nephrolithiasis or renal calculi, is a hard and crystalline mineral deposit that develops within the kidneys. These stones exhibit variability in both size and shape and can cause intense discomfort as they traverse the urinary tract. Kidney stones can develop due to an imbalance in urine composition, specifically in the levels of calcium, oxalate, and uric acid.
Download a Free Sample To learn more about this report,
Rising Adoption of Minimally Invasive and Laser-Based Kidney Stone Treatment Technologies
The increasing adoption of minimally invasive procedures and advanced laser technologies is a key trend shaping the Kidney Stones Market. Healthcare providers are increasingly preferring treatments such as ureteroscopy (URS), percutaneous nephrolithotomy (PCNL), and laser lithotripsy due to their high success rates, reduced postoperative pain, shorter hospital stays, and faster patient recovery. Technological advancements in flexible ureteroscopes, high-power laser systems, and digital imaging have improved the precision and safety of kidney stone removal. In addition, the growing availability of outpatient treatment options and rising awareness of early diagnosis are further driving the adoption of these advanced treatment modalities.
Rising Prevalence of Kidney Stones Drives Demand for Advanced Diagnosis and Treatment
The increasing incidence of kidney stones is a major driver of the Kidney Stones Market. Sedentary lifestyles, unhealthy dietary habits, obesity, diabetes, and inadequate water intake have contributed to a growing number of kidney stone cases worldwide. The rising disease burden has increased the demand for early diagnosis, effective treatment options, and preventive care. Healthcare providers are expanding access to advanced diagnostic imaging and specialized urology services to address the growing patient population, while ongoing awareness initiatives are encouraging timely medical intervention.
Growing Preference for Minimally Invasive Procedures Accelerates Market Growth
The increasing demand for minimally invasive kidney stone treatments is significantly driving market growth. Patients and healthcare providers are increasingly opting for procedures such as extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, and laser lithotripsy due to their shorter recovery times, lower complication rates, reduced postoperative pain, and improved clinical outcomes. Continuous technological advancements in stone fragmentation devices and endoscopic equipment are further enhancing treatment efficiency while reducing hospital stays and overall healthcare costs.
High Treatment Costs and Limited Insurance Coverage Restrict Market Growth
The high cost of kidney stone diagnosis and treatment, coupled with limited insurance coverage in several regions, is a significant restraint on the Kidney Stones Market. Expenses associated with diagnostic imaging, specialist consultations, medications, extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, and surgical procedures can place a considerable financial burden on patients. Even where health insurance is available, high deductibles, copayments, and out-of-pocket expenses may discourage individuals from seeking timely treatment or choosing advanced therapeutic options. These financial barriers can delay diagnosis, increase the risk of disease progression, and limit the adoption of innovative kidney stone treatment technologies.
Advancements in Stone Management Technologies Create Significant Growth Opportunities
Continuous advancements in kidney stone diagnosis and treatment technologies are creating substantial growth opportunities for the Kidney Stones Market. Innovations such as high-power laser lithotripsy systems, flexible ureteroscopes, digital imaging, robotic-assisted urological procedures, and artificial intelligence (AI)-enabled diagnostic tools are improving treatment precision, reducing procedure times, and enhancing patient outcomes. In addition, increasing investments in outpatient care facilities and ambulatory surgical centers are expanding access to minimally invasive treatments, enabling healthcare providers to deliver cost-effective and efficient stone management solutions.
High Recurrence Rates and Limited Long-Term Prevention Strategies Challenge Market Growth
The high recurrence rate of kidney stones remains a major challenge for the Kidney Stones Market. Many patients experience recurrent stone formation despite successful treatment, requiring repeated diagnostic evaluations, medical interventions, and long-term follow-up care. Preventing recurrence often depends on sustained lifestyle modifications, dietary management, adequate hydration, and adherence to prescribed medications, which many patients find difficult to maintain over the long term. This increases healthcare costs, places additional pressure on healthcare systems, and highlights the need for more effective preventive therapies and personalized disease management strategies.
Request Customizationto receive a tailored report.
Calcium Oxalate Stones Segment Dominated the Market with a 58.3% Share in 2025
The calcium oxalate stones segment dominated the kidney stones market, accounting for 58.3% of the market share in 2025. The high prevalence of calcium oxalate stones is primarily attributed to dietary habits, inadequate fluid intake, obesity, and metabolic disorders.
The uric acid stones, struvite kidney stones, cystine stones, and calcium phosphate stones segments continue to contribute to market growth. Rising awareness of metabolic and genetic disorders, along with advancements in diagnostic technologies and personalized treatment approaches, is improving the management of these less common kidney stone types.
Ureteroscopy Segment is Expected to Register the Highest CAGR of 7.26% During the Forecast Period
The ureteroscopy segment is projected to grow at the fastest CAGR of 7.26% during the forecast period. The increasing preference for minimally invasive procedures, high stone-free success rates, shorter hospital stays, and faster patient recovery are driving the adoption of ureteroscopy.
The medications, extracorporeal shock wave lithotripsy (ESWL), and percutaneous nephrolithotomy (PCNL) segments continue to play a vital role in kidney stone management. These treatment options are selected based on stone size, composition, and location, offering effective solutions for both uncomplicated and complex kidney stone cases.
Ultrasound Segment Dominated the Market with a 25.8% Share in 2025
The ultrasound segment dominated the kidney stones market, accounting for 25.8% of the market share in 2025. Ultrasound is widely preferred as a first-line diagnostic tool due to its non-invasive nature, absence of radiation exposure, cost-effectiveness, and ability to detect kidney stones efficiently.
The intravenous pyelography, CT scan, X-ray, and other diagnostic methods remain important in kidney stone diagnosis. These imaging techniques provide detailed anatomical information, assist in identifying stone size and location, and support treatment planning, particularly in complex or recurrent kidney stone cases.
Speak to an Analystto discuss market opportunities.
North America dominated the global Kidney Stones Market with a 38.4% share, valued at USD 1.09 billion in 2025, and is projected to grow at a CAGR of 6.42% during the forecast period. The region's growth is driven by the high prevalence of kidney stone disease, increasing adoption of minimally invasive treatment procedures, advanced healthcare infrastructure, and growing awareness regarding early diagnosis and preventive care.
The United States kidney stones market was valued at USD 0.94 billion in 2025. Market growth is driven by the rising incidence of kidney stones, increasing adoption of laser lithotripsy and ureteroscopy, expanding access to advanced diagnostic imaging, and favorable reimbursement for urological procedures.
The Canada kidney stones market reached USD 0.15 billion in 2025. Increasing awareness of kidney stone prevention, improved access to minimally invasive treatments, growing healthcare expenditure, and expanding diagnostic capabilities are supporting market growth.
Europe accounted for 27.1% of the global Kidney Stones Market, valued at USD 0.77 billion in 2025, and is expected to grow at a CAGR of 6.18% during the forecast period. Market growth is supported by the increasing prevalence of urological disorders, rising adoption of advanced endoscopic procedures, favorable healthcare systems, and continuous investments in medical technologies across the region.
The Germany kidney stones market was valued at USD 0.42 billion in 2025. Growth is driven by advanced healthcare infrastructure, widespread availability of minimally invasive surgical procedures, increasing investments in medical technology, and growing demand for early diagnosis.
The United Kingdom kidney stones market reached USD 0.35 billion in 2025. Increasing incidence of kidney stone disease, expanding access to advanced urology care, rising healthcare spending, and growing adoption of outpatient treatment procedures continue to drive market expansion.
Asia Pacific held 22.6% of the global Kidney Stones Market, valued at USD 0.64 billion in 2025, and is projected to grow at a CAGR of 7.89% during the forecast period. Rising healthcare investments, improving diagnostic infrastructure, increasing awareness of kidney health, and the growing prevalence of lifestyle-related diseases are driving market growth across the region.
The China kidney stones market was valued at USD 0.37 billion in 2025. Rapid improvements in healthcare infrastructure, increasing availability of advanced urology procedures, rising patient awareness, and a large patient population continue to support market expansion.
The Japan kidney stones market reached USD 0.27 billion in 2025. The market is driven by an aging population, high adoption of minimally invasive treatment technologies, advanced diagnostic capabilities, and increasing demand for precision urology care.
Latin America accounted for 6.8% of the global Kidney Stones Market, valued at USD 0.19 billion in 2025, and is expected to grow at a CAGR of 6.63% during the forecast period. Growing healthcare access, rising awareness of kidney stone management, increasing adoption of minimally invasive procedures, and improving medical infrastructure are contributing to regional market growth.
The Brazil kidney stones market reached USD 0.19 billion in 2025. Increasing healthcare investments, expanding access to urology specialists, rising prevalence of kidney stones, and improving diagnostic services are driving market growth.
The Middle East & Africa accounted for 5.1% of the global Kidney Stones Market, valued at USD 0.14 billion in 2025, and is projected to grow at a CAGR of 6.31% during the forecast period. Market growth is supported by increasing healthcare expenditure, rising awareness of kidney health, expanding hospital infrastructure, and growing adoption of advanced diagnostic and treatment technologies.
The UAE kidney stones market was valued at USD 0.14 billion in 2025. Growth is driven by advanced healthcare facilities, increasing prevalence of kidney stone disease associated with hot climatic conditions, rising demand for minimally invasive procedures, and government initiatives to strengthen specialty healthcare services.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com